Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’ Pulmonary Nodules
暂无分享,去创建一个
P. Shah | Shaohui Hu | J. Borgia | M. Liptay | C. Seder | Ahmed E. Abdelkader | S. Basu | C. Fhied | I. Tarhoni | H. Moudgalya | D. Gerard | T. Hulett | Claire Auger | Matthew R. Neely | Jeremy T. Stephan | Moises Vargas | J. Stephan
[1] D. Fenyo,et al. Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] J. Borgia,et al. Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19. , 2022, Journal of visualized experiments : JoVE.
[3] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[4] P. Jousilahti,et al. Incidence trends and risk factors of lung cancer in never smokers: Pooled analyses of seven cohorts , 2021, International journal of cancer.
[5] T. Hansen,et al. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort. , 2021, Lung cancer.
[6] E. Dharaiya,et al. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial. , 2021, Radiology.
[7] M. Cabana,et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.
[8] B. van Ginneken,et al. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval , 2020, European Radiology.
[9] J. Vilo,et al. PAWER: protein array web exploreR , 2020, BMC Bioinformatics.
[10] Alboukadel Kassambara,et al. Pipe-Friendly Framework for Basic Statistical Tests [R package rstatix version 0.6.0] , 2020 .
[11] Sadiq S. Rehmani,et al. Lung Cancer Screening Uptake in the United States. , 2020, Chest.
[12] H. Sampson,et al. Novel Bead-Based Epitope Assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy , 2019, Scientific Reports.
[13] Kohske Takahashi,et al. Welcome to the Tidyverse , 2019, J. Open Source Softw..
[14] Hong Huang,et al. The diagnostic efficiency of seven autoantibodies in lung cancer , 2019, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[15] J. Platt,et al. The five dimensions of B cell tolerance , 2019, Immunological reviews.
[16] N. Nguyen,et al. Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches. , 2019, Biosensors & bioelectronics.
[17] Bin Yang,et al. Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review , 2019, Cell Death Discovery.
[18] G. Rubin,et al. A Geospatial Analysis of Factors Affecting Access to CT Facilities: Implications for Lung Cancer Screening. , 2019, Journal of the American College of Radiology : JACR.
[19] Randle Aaron M. Villanueva,et al. ggplot2: Elegant Graphics for Data Analysis (2nd ed.) , 2019, Measurement: Interdisciplinary Research and Perspectives.
[20] T. Kirchhoff,et al. Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors , 2018, Journal of Translational Medicine.
[21] J. Borgia,et al. Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum , 2018, Journal of immunoassay & immunochemistry.
[22] Ahmedin Jemal,et al. Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.
[23] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[24] J. Borgia,et al. Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical setting. , 2014, Journal of immunological methods.
[25] Xiaoju Wang,et al. Development of a Multiplex Autoantibody Test for Detection of Lung Cancer , 2014, PloS one.
[26] P. Pinsky. Assessing the benefits and harms of low-dose computed tomography screening for lung cancer. , 2014, Lung cancer management.
[27] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[28] S. Lam,et al. EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer , 2011, Cancer Prevention Research.
[29] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[30] Sanjib Basu,et al. Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.
[31] Sanjib Basu,et al. Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[32] Max Kuhn,et al. The caret Package , 2007 .
[33] Leo Breiman,et al. Random Forests , 2001, Machine Learning.